missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ AGTR2 Polyclonal Antibody

Description
PA3-210 detects AGTR2 in human samples. PA3-210 has successfully been used in Western blot, immunocytochemical, and immunohistochemical (paraffin) procedures. The PA3-210 immunogen is a synthetic peptide corresponding to the C-terminal amino acids C(349)RKSSSLREMETFVS(363) of AGTR2.
Angiotensin II is a potent vasopressor hormone and a primary regulator of aldosterone secretion that acts through at least two types of receptors, AGTR1 and AGTR2. It is an important effector controlling blood pressure and volume in the cardiovascular system and plays a major role in the development of the mammalian kidney and urinary tract. Like AGTR1, AGTR2 is a seven transmembrane G protein-coupled receptor (GPCR), but AGTR2 does not demonstrate most of the classic features of GPCR signaling. AGTR2 is involved in a wide range of activities, including the induction of neurite outgrowth and the inhibition of cellular proliferation, in addition to the known function of mediation of vasoconstriction.
Specifications
Specifications
| Antigen | AGTR2 |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | Conc. Not Determined |
| Conjugate | Unconjugated |
| Formulation | whole serum with 0.02% sodium azide |
| Gene | Agtr2 |
| Gene Accession No. | P50052 |
| Gene Alias | AGTR2; AI316812; Angiotensin ii at2; angiotensin II receptor type 2; angiotensin II receptor, type 2; angiotensin II type 2 receptor; angiotensin II type-2 receptor; angiotensin receptor 2; AT>sub>2>/sub>R; AT2; AT2 receptor; AT2R; AT2-R; ATGR2; AW107640; MRX88; type-2 angiotensin II receptor |
| Gene Symbols | Agtr2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?